In line with this, the interrogation of the Cancer Genome Atlas and other publicly available datasets uncovered a positive association between FASN expression and worse clinico-pathological features, including Gleason grade, tumor stage, lymph node positivity, shorter time to recurrence, cancer-free survival, and overall survival [reviewed in (17)]. Here, FASN is linked to cancer.